Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon

We conducted 2 independent population-based SARS-CoV-2 serosurveys in Yaoundé, Cameroon, during January 27–February 6 and April 24–May 19, 2021. Overall age-standardized SARS-CoV-2 IgG seroprevalence increased from 18.6% in the first survey to 51.3% in the second (p<0.001). This finding illustra...

Full description

Bibliographic Details
Main Authors: Francis Ateba Ndongo, Emilande Guichet, Eric Donald Mimbé, Justin Ndié, Raphael Pelloquin, Marie Varloteaux, Livo Esemu, Mireille Mpoudi-Etame, Nadine Lamare, Ginette Edoul, Rodrigue Kamga Wouambo, Dowbiss Meta Djomsi, Marcel Tongo, Félicité Naah Tabala, Rogacien Kana Dongmo, Mamadou Saliou Kalifa Diallo, Julie Bouillin, Guillaume Thaurignac, Ahidjo Ayouba, Martine Peeters, Eric Delaporte, Anne-Cécile Zoung-Kanyi Bissek, Eitel Mpoudi-Ngolé
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2022-06-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/28/6/21-2580_article
_version_ 1818231256335253504
author Francis Ateba Ndongo
Emilande Guichet
Eric Donald Mimbé
Justin Ndié
Raphael Pelloquin
Marie Varloteaux
Livo Esemu
Mireille Mpoudi-Etame
Nadine Lamare
Ginette Edoul
Rodrigue Kamga Wouambo
Dowbiss Meta Djomsi
Marcel Tongo
Félicité Naah Tabala
Rogacien Kana Dongmo
Mamadou Saliou Kalifa Diallo
Julie Bouillin
Guillaume Thaurignac
Ahidjo Ayouba
Martine Peeters
Eric Delaporte
Anne-Cécile Zoung-Kanyi Bissek
Eitel Mpoudi-Ngolé
author_facet Francis Ateba Ndongo
Emilande Guichet
Eric Donald Mimbé
Justin Ndié
Raphael Pelloquin
Marie Varloteaux
Livo Esemu
Mireille Mpoudi-Etame
Nadine Lamare
Ginette Edoul
Rodrigue Kamga Wouambo
Dowbiss Meta Djomsi
Marcel Tongo
Félicité Naah Tabala
Rogacien Kana Dongmo
Mamadou Saliou Kalifa Diallo
Julie Bouillin
Guillaume Thaurignac
Ahidjo Ayouba
Martine Peeters
Eric Delaporte
Anne-Cécile Zoung-Kanyi Bissek
Eitel Mpoudi-Ngolé
author_sort Francis Ateba Ndongo
collection DOAJ
description We conducted 2 independent population-based SARS-CoV-2 serosurveys in Yaoundé, Cameroon, during January 27–February 6 and April 24–May 19, 2021. Overall age-standardized SARS-CoV-2 IgG seroprevalence increased from 18.6% in the first survey to 51.3% in the second (p<0.001). This finding illustrates high community transmission during the second wave of COVID-19.
first_indexed 2024-12-12T10:47:30Z
format Article
id doaj.art-c5a73a1dfb9f405f87fee0ab5726f18b
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-12-12T10:47:30Z
publishDate 2022-06-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-c5a73a1dfb9f405f87fee0ab5726f18b2022-12-22T00:26:52ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592022-06-012861233123610.3201/eid2806.212580Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, CameroonFrancis Ateba NdongoEmilande GuichetEric Donald MimbéJustin NdiéRaphael PelloquinMarie VarloteauxLivo EsemuMireille Mpoudi-EtameNadine LamareGinette EdoulRodrigue Kamga WouamboDowbiss Meta DjomsiMarcel TongoFélicité Naah TabalaRogacien Kana DongmoMamadou Saliou Kalifa DialloJulie BouillinGuillaume ThaurignacAhidjo AyoubaMartine PeetersEric DelaporteAnne-Cécile Zoung-Kanyi BissekEitel Mpoudi-Ngolé We conducted 2 independent population-based SARS-CoV-2 serosurveys in Yaoundé, Cameroon, during January 27–February 6 and April 24–May 19, 2021. Overall age-standardized SARS-CoV-2 IgG seroprevalence increased from 18.6% in the first survey to 51.3% in the second (p<0.001). This finding illustrates high community transmission during the second wave of COVID-19. https://wwwnc.cdc.gov/eid/article/28/6/21-2580_articleCOVID-19SARS-CoV-2antibodiesseroepidemiologic studiesCamerooncoronavirus disease
spellingShingle Francis Ateba Ndongo
Emilande Guichet
Eric Donald Mimbé
Justin Ndié
Raphael Pelloquin
Marie Varloteaux
Livo Esemu
Mireille Mpoudi-Etame
Nadine Lamare
Ginette Edoul
Rodrigue Kamga Wouambo
Dowbiss Meta Djomsi
Marcel Tongo
Félicité Naah Tabala
Rogacien Kana Dongmo
Mamadou Saliou Kalifa Diallo
Julie Bouillin
Guillaume Thaurignac
Ahidjo Ayouba
Martine Peeters
Eric Delaporte
Anne-Cécile Zoung-Kanyi Bissek
Eitel Mpoudi-Ngolé
Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon
Emerging Infectious Diseases
COVID-19
SARS-CoV-2
antibodies
seroepidemiologic studies
Cameroon
coronavirus disease
title Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon
title_full Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon
title_fullStr Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon
title_full_unstemmed Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon
title_short Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon
title_sort rapid increase of community sars cov 2 seroprevalence during second wave of covid 19 yaounde cameroon
topic COVID-19
SARS-CoV-2
antibodies
seroepidemiologic studies
Cameroon
coronavirus disease
url https://wwwnc.cdc.gov/eid/article/28/6/21-2580_article
work_keys_str_mv AT francisatebandongo rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT emilandeguichet rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT ericdonaldmimbe rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT justinndie rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT raphaelpelloquin rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT marievarloteaux rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT livoesemu rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT mireillempoudietame rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT nadinelamare rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT ginetteedoul rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT rodriguekamgawouambo rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT dowbissmetadjomsi rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT marceltongo rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT felicitenaahtabala rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT rogacienkanadongmo rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT mamadousalioukalifadiallo rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT juliebouillin rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT guillaumethaurignac rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT ahidjoayouba rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT martinepeeters rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT ericdelaporte rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT annececilezoungkanyibissek rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon
AT eitelmpoudingole rapidincreaseofcommunitysarscov2seroprevalenceduringsecondwaveofcovid19yaoundecameroon